A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Oprah Winfrey has been slammed for her controversial comments about 'thin people' while discussing her use of weight loss ...

Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent ...

An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

The risk of heart attack and stroke declines, but gastrointestinal problems and joint inflammation increase: New research has shed more light on the pros and cons of weight-loss jabs.

She explained that the weight-loss drug allowed her to experience what she had once perceived ... "This just makes me mad. You make your own GLP1 in your gut when your nutrition and exercise are on ...

A new study reports that GLP-1 medications may provide benefits to cognitive and behavioral health, including lowered ...

Commonly used diabetes drugs could lower the risk of cardiometabolic conditions but heighten the risk of gastrointestinal and arthritic ones, hypotension, among others, according to a study.